Finally, we identify that CRABP2 is upregulated in ovarian cancer tissues and can be detected at a higher level in the exosome of patients, which might serve as a biomarker and surmount the obstacles in the early diagnosis and targeted therapy of ovarian carcinoma. The gene discussed is CRABP2; the disease is ovarian cancer.